NCT06492148

Brief Summary

It has been found that women with dysmenorrhea have active trigger points, particularly in the rectus abdominis, oblique abdominal muscles, quadratus lumborum, and paraspinal muscles. The myofascial release technique is a widely used manual therapy method characterized by the application of low-load, long-duration mechanical forces to manipulate the myofascial complex. This technique aims to restore optimal length, alleviate pain, and improve function. This study aims to examine the effect of the myofascial release technique on central sensitization, myofascial trigger points, and menstrual symptoms in women with primary dysmenorrhea.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2024

Completed
28 days until next milestone

First Posted

Study publicly available on registry

July 9, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

September 10, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 2, 2024

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 25, 2025

Completed
Last Updated

November 21, 2024

Status Verified

November 1, 2024

Enrollment Period

3 months

First QC Date

June 11, 2024

Last Update Submit

November 19, 2024

Conditions

Keywords

myofascial releasetrigger pointCentral sensitizationDysmenorrheasham

Outcome Measures

Primary Outcomes (6)

  • Pain Pressure Threshold

    Trigger points in specific muscles (rectus abdominis, paraspinal muscles, quadratus lumborum, gluteus maximus) will be determined. Then, it will be applied to the trigger points with the Baseline brand algometer in accordance with standard procedures and the pressure will be increased by 30 kPa/s.

    Baseline (First menstruation cycle)

  • Pain Pressure Threshold

    Trigger points in specific muscles (rectus abdominis, paraspinal muscles, quadratus lumborum, gluteus maximus) will be determined. Then, it will be applied to the trigger points with the Baseline brand algometer in accordance with standard procedures and the pressure will be increased by 30 kPa/s.

    through study completion, an average of 3 months

  • Central Sensitization

    Pain threshold will be measured with an algometer at a certain point of the tibialis muscle.

    Baseline (First menstruation cycle)

  • Central Sensitization

    Pain threshold will be measured with an algometer at a certain point of the tibialis muscle.

    through study completion, an average of 3 months

  • Menstrual pain intensity

    Menstrual pain intensity will be determined by a 10 cm Visual Analog Scale ranging from zero (no pain at all) to 10 (worst pain I have ever felt). Higher scores mean worse conditions. Participants will be asked to mark the severity of pain they felt in the first 3 days of their last menstrual bleeding on 3 separate lines.

    Baseline (First menstruation cycle)

  • Menstrual pain intensity

    Menstrual pain intensity will be determined by a 10 cm Visual Analog Scale ranging from zero (no pain at all) to 10 (worst pain I have ever felt). Higher scores mean worse conditions. Participants will be asked to mark the severity of pain they felt in the first 3 days of their last menstrual bleeding on 3 separate lines.

    through study completion, an average of 3 months

Secondary Outcomes (8)

  • Menstrual Attitude

    Baseline (First menstruation cycle)

  • Menstrual Attitude

    through study completion, an average of 3 months

  • Health-related quality of life

    Baseline (First menstruation cycle)

  • Health-related quality of life

    through study completion, an average of 3 months

  • Anxiety

    Baseline (First menstruation cycle)

  • +3 more secondary outcomes

Study Arms (2)

Myofascial Release Group

ACTIVE COMPARATOR

The technique known as myofascial release, also referred to as cross-hand release, will be applied to 7 regions. Among these regions are the lateral abdominal wall (right and left), the lower abdomen with the opposite side medial thigh (right and left crossed), the thoracolumbar fascia (bilateral), and the lumbosacral region. In the cross-hand technique, hands will be gently placed on the specified regions and directions. The release of the barriers of the tissue under the hands will be ensured, and the technique will be applied until a wave or oscillation is felt. A myofascial release technique with an optimal duration of 5 minutes will be applied to each region. The total treatment time will be 35 minutes.

Other: Myofascial Release

Sham- Myofascial Release Group

SHAM COMPARATOR

The hands of the researcher applying the technique will be positioned on the same regions as the myofascial release technique, with only the palms lightly touching for the same duration. However, there will be no intervention aimed at applying pressure or opening tissue barriers. The total sham treatment time will be 35 minutes.

Other: Sham-Myofascial Release

Interventions

The myofascial release technique is a widely used manual therapy method characterized by low-load, prolonged mechanical forces applied to manipulate the myofascial complex, aiming to restore optimal length, alleviate pain, and improve function.

Myofascial Release Group

The hands of the researcher applying the technique will be placed in the same areas as the myofascial release technique, with only the palms in light contact for the same duration. However, no intervention will be made to create any pressure or open the tissue barrier.

Sham- Myofascial Release Group

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosed with Primary Dysmenorrhea according to the Primary Dysmenorrhea Consensus Guide,
  • Having regular menstruation in the last 6 months (28±7 days)
  • Those who had menstrual pain between 40 mm and 100 mm according to the Visual Analogue Scale (VAS) in the last 6 months

You may not qualify if:

  • Diagnosed with Secondary Dysmenorrhea,
  • Having given birth,
  • Those with serious gastrointestinal, urogynecological, or autoimmune diseases or other chronic pain syndromes,
  • Undergoing urogynecological surgery,
  • Those who are pregnant or suspected of pregnancy,
  • Those who use analgesics or non-pharmacological agents other than NSAIDs for menstrual pain,
  • Those using intrauterine or oral contraceptives,
  • Those taking extra supplements such as magnesium, which may affect treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Gazi University

Ankara, 06530, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Myofascial Pain SyndromesDysmenorrhea

Interventions

Myofascial Release Therapy

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesMenstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and SymptomsPelvic PainPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

MassageTherapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Beyza Yazgan Dagli

    Gazi University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Research Asisstant

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

June 11, 2024

First Posted

July 9, 2024

Study Start

September 10, 2024

Primary Completion

December 2, 2024

Study Completion

September 25, 2025

Last Updated

November 21, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations